| Acupuncture for Chemo-Induced Peripheral Neuropathy (NCT00891618) | M.D. Anderson Cancer Center | 2009-04-01 |
| Rituximab, Cladribine, and Temsirolimus in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma (NCT00787969) | Alliance for Clinical Trials in Oncology | 2009-04-01 |
| S8516-S8736-S9125-S9240 Research Study of Genes in Tissue Samples From Patients With B-cell Non-Hodgkin Lymphoma (NCT00985699) | SWOG Cancer Research Network | 2009-04-01 |
| Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia (NCT00882206) | Masonic Cancer Center, University of Minnesota | 2009-04-01 |
| Thiotepa-Clofarabine-Busulfan With Allogeneic Stem Cell Transplant for High Risk Malignancies (NCT00857389) | M.D. Anderson Cancer Center | 2009-03-02 |
| Methadone, Morphine, or Oxycodone in Treating Pain in Patients With Cancer (NCT00726830) | M.D. Anderson Cancer Center | 2009-03-01 |
| Comparison Study of Doxorubicin Versus Epirubicin-induced Cardiotoxicity in Patients With DLBCL (NCT00854568) | Fudan University | 2009-03-01 |
| GM-CSF and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma (NCT00893477) | French Innovative Leukemia Organisation | 2009-03-01 |
| GM-CSF, Rituximab, and Combination Chemotherapy in Treating Patients With Previously Untreated Advanced Follicular Non-Hodgkin Lymphoma (NCT00896519) | French Innovative Leukemia Organisation | 2009-03-01 |
| Positron Emission Tomography/Computed Tomography (PET/CT) for the Diagnosis of Recurrent Cancer: a Feasibility Study (NCT00686465) | Ontario Clinical Oncology Group (OCOG) | 2009-03-01 |
| Assessing Antibody Responsiveness to Hepatitis B Vaccine in Aged Lymphoma Patients Undergoing Treatment With Rituximab (NCT00863187) | Rambam Health Care Campus | 2009-02-01 |
| Observational Study of Diffuse Large B Cell Primary Breast Lymphomas Treated With RCHOP +/- XRT (NCT01144754) | Stanford University | 2009-02-01 |
| Lenalidomide With or Without Rituximab in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma Who Have Undergone Autologous or Syngeneic Stem Cell Transplant (NCT00833534) | Fred Hutchinson Cancer Center | 2009-02-01 |
| Creation of a Normal Database for FluoroDeoxyGlucose-Positron Emission Tomography (FDG-PET) Neurological Examinations (NCT02858167) | Central Hospital, Nancy, France | 2009-02-01 |
| Pentostatin, Cyclophosphamide, and Rituximab With or Without Bevacizumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00816595) | Mayo Clinic | 2009-02-01 |
| Rituximab, Gemcitabine, and Vinorelbine in Treating Patients With Hodgkin Lymphoma That Has Relapsed or Not Responded to Treatment (NCT00881387) | University of Miami | 2009-02-01 |
| Combination of Vorinostat and Bortezomib in Relapsed or Refractory T-Cell Non-Hodgkin's Lymphoma (NCT00810576) | M.D. Anderson Cancer Center | 2009-01-01 |
| Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment (NCT00829205) | Cancer Research UK | 2009-01-01 |
| Donor Natural Killer Cells After Donor Stem Cell Transplant in Treating Patients With Advanced Cancer (NCT00823524) | Asan Medical Center | 2009-01-01 |
| A Phase 2 Intratumoral Injection PF-3512676 Plus Local Radiation in Low-Grade B-Cell Lymphomas (NCT00880581) | Ronald Levy | 2009-01-01 |
| Diffuse Large B Cell Non-Hodgkin's Lymphoma in the Vulnerable/Frail Elderly. A Multicentric Randomized Phase II Trial (NCT00911183) | Institut Bergonié | 2008-12-02 |
| ZAR2007: R-CHOP in Folicular Lymphoma Patients no Treated Previously. Consolidation With 90Y Ibritumomab Tiuxetan (Zevalin®) Versus Maintenance Treatment With Rituximab (MabThera®) (NCT00662948) | PETHEMA Foundation | 2008-12-01 |
| S8809-S9800-S9911-S9704-A Study of Blood and Tissue Samples From Patients With Follicular Lymphoma Treated With Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (NCT00933127) | SWOG Cancer Research Network | 2008-12-01 |
| Safety and Pharmacologic Study of VTX-2337 in Patients With Advanced Cancer (NCT00688415) | Celgene | 2008-11-07 |
| RFT5-dgA Immunotoxin in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma (NCT00667017) | University of Texas Southwestern Medical Center | 2008-11-07 |
| Pilot Study of MGd + High-dose MTX-Based Chemoimmunotherapy + RT for Newly Dx PCNSL (NCT00734773) | Northwestern University | 2008-11-01 |
| Combination Chemotherapy in Treating Patients With Burkitt's Lymphoma or Burkitt's Leukemia (NCT00040690) | Medical Research Council | 2008-11-01 |
| Donor Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma (NCT00720447) | Cancer Research UK | 2008-11-01 |
| Lenalidomide, Rituximab, Cyclophosphamide, and Dexamethasone in Treating Patients With Previously Untreated Low-Grade Non-Hodgkin Lymphoma (NCT00784927) | Mayo Clinic | 2008-11-01 |
| SAHA + CHOP in Untreated T-cell Non-Hodgkin's Lymphoma (NCT00787527) | M.D. Anderson Cancer Center | 2008-11-01 |
| Total Marrow and Total Lymph Node Irradiation, Fludarabine, and Melphalan Followed By Donor Stem Cell Transplant in Treating Patients With Advanced Hematological Cancer That Has Not Responded to Treatment (NCT00800150) | City of Hope Medical Center | 2008-11-01 |
| Influenza Vaccine in Preventing Flu in Patients Who Have Undergone Stem Cell Transplant and in Healthy Volunteers (NCT00952185) | City of Hope Medical Center | 2008-11-01 |
| Pazopanib to Treat Adults With Advanced Cancers and Varying Degrees of Liver Function (NCT00674024) | National Cancer Institute (NCI) | 2008-10-07 |
| American Ginseng in Treating Patients With Fatigue Caused by Cancer (NCT00719563) | Alliance for Clinical Trials in Oncology | 2008-10-01 |
| Combination Chemotherapy, Donor Stem Cell Transplant, Tacrolimus, Mycophenolate Mofetil, and Cyclophosphamide in Treating Patients With Hematologic Cancer (NCT00782379) | Northside Hospital, Inc. | 2008-10-01 |
| Lenalidomide With or Without Rituximab After Standard Chemotherapy in Treating Patients With Diffuse Large B-Cell Non-Hodgkin Lymphoma (NCT00765245) | Vanderbilt-Ingram Cancer Center | 2008-10-01 |
| Quality of Life in Younger Leukemia and Lymphoma Survivors (NCT00956475) | Case Comprehensive Cancer Center | 2008-10-01 |
| Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder (NCT00755040) | Vanderbilt-Ingram Cancer Center | 2008-10-01 |
| Epstein-Barr Virus (EBV)-Specific T Cells as Therapy for Relapsed/Refractory EBV-positive Lymphomas (NCT00779337) | Queensland Institute of Medical Research | 2008-10-01 |
| 18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma (NCT00775268) | National Cancer Institute (NCI) | 2008-09-29 |
| Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors (NCT00788125) | City of Hope Medical Center | 2008-09-03 |
| Busulfan and Fludarabine Followed by Post-transplant Cyclophosphamide (NCT00800839) | M.D. Anderson Cancer Center | 2008-09-01 |
| Study of Pegylated Interferon-Alfa 2b in Combination With PUVA Therapy In CTCL (NCT00724061) | Northwestern University | 2008-09-01 |
| S0629, Observation or Combination Chemotherapy, Bortezomib, Thalidomide, and Rituximab Followed By Two Autologous Peripheral Blood Stem Cell Transplants in Treating Patients With Waldenstrom Macroglobulinemia (NCT00723658) | SWOG Cancer Research Network | 2008-09-01 |
| Stem Cell Mobilization With Pegfilgrastim in Lymphoma and Myeloma (NCT00794261) | Centre Leon Berard | 2008-09-01 |
| Donor Stem Cell Transplant, Pentostatin, and Total-Body Irradiation in Treating Patients With Hematological Cancer (NCT00816413) | University of Nebraska | 2008-09-01 |
| Prospective Observational Study on Plerixafor After Chemotherapy (NCT01700608) | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | 2008-09-01 |
| Samsung Medical Center-Lymphoma Cohort Study (NCT00822731) | Samsung Medical Center | 2008-09-01 |
| Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma (NCT00678327) | University College, London | 2008-08-29 |
| Lenalidomide, Rituximab, and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Diffuse Large Cell or Follicular B-Cell Lymphoma (NCT00670358) | Mayo Clinic | 2008-08-25 |
| Lenalidomide and Rituximab in Treating Patients With Non-Hodgkin Lymphoma (NCT00848328) | University of California, Davis | 2008-08-25 |
| Safety & Pharmacokinetics Study Of Azacitidine (SC And Oral) In Subjects With MDS, CMML, AML, Lymphoma And Multiple Myeloma (NCT00761722) | Celgene | 2008-08-12 |
| Validation of a Screening Tool in Geriatric Oncology (NCT00963911) | Institut Bergonié | 2008-08-05 |
| Vorinostat (MK-0683) Phase I Study in Cutaneous T-Cell Lymphoma (CTCL) Patients (MK-0683-089 EXT1) (NCT00771472) | Merck Sharp & Dohme LLC | 2008-08-01 |
| Feasibility and Efficacy Study of Conditioning Regimen for Allogeneic Hematopoietic Cell Transplantation (HCT) With Fludarabine, Busulfan, and Total Body Irradiation (TBI) (NCT00815568) | Samsung Medical Center | 2008-08-01 |
| A Open Label Phase I/II Clinical Trial to Evaluate CPI-613 in Patients With Advanced Malignancies (NCT00741403) | Cornerstone Pharmaceuticals | 2008-08-01 |
| Blood Samples From Patients on a Clinical Trial to CINV During HSCT (NCT00900068) | OHSU Knight Cancer Institute | 2008-08-01 |
| Vorinostat and Rituximab in Treating Patients With Indolent Non-Hodgkin Lymphoma (NCT00720876) | City of Hope Medical Center | 2008-07-23 |
| Study of the Safety and Tolerability of PCI-24781 in Patients With Lymphoma (NCT00724984) | Pharmacyclics LLC. | 2008-07-01 |
| Intratumoral Dendritic Cell Vaccination Combined With Local Radiotherapy in Patients With Recurrent Lymphoma. (NCT00637117) | Baylor Research Institute | 2008-07-01 |
| A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer (NCT00754286) | Albert Einstein College of Medicine | 2008-07-01 |
| Pentostatin, Alemtuzumab, and Rituximab in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma (NCT00669318) | Mayo Clinic | 2008-07-01 |
| Methotrexate, Glucarpidase, and Leucovorin in Treating Patients With Newly Diagnosed Primary Central Nervous System Lymphoma (NCT00727831) | University College, London | 2008-07-01 |
| Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic Cancer (NCT00723099) | Fred Hutchinson Cancer Center | 2008-06-25 |
| Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant (NCT00725062) | Masonic Cancer Center, University of Minnesota | 2008-06-01 |
| Immunologic Diagnostic Blood Test in Predicting Side-Effects in Patients Undergoing a Donor Stem Cell Transplant for Hematologic Cancer or Other Diseases (NCT00813501) | City of Hope Medical Center | 2008-06-01 |
| L-asparaginase Monotherapy as Salvage Treatment in Patients With NK/T Cell Lymphoma (NCT00854425) | Fudan University | 2008-06-01 |
| A Web-Based Stem Cell Transplant Support System or Standard Care in Young Patients Undergoing Stem Cell Transplant and Their Families (NCT00782145) | Tufts Medical Center | 2008-06-01 |
| Study of MLN4924, a Novel Inhibitor of Nedd8 Activating Enzyme, in Adult Patients With Lymphoma or Multiple Myeloma (NCT00722488) | Millennium Pharmaceuticals, Inc. | 2008-06-01 |
| Everolimus and Bortezomib in Treating Patients With Relapsed or Refractory Lymphoma (NCT00671112) | Brian Hill, MD, PhD | 2008-06-01 |
| Bendamustine HCL in Relapsed and Primary Refractory Hodgkin Lymphoma (NCT00705250) | Memorial Sloan Kettering Cancer Center | 2008-06-01 |
| Galiximab in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma (NCT00516217) | Alliance for Clinical Trials in Oncology | 2008-06-01 |
| Detecting Anal and Genital Human Papillomavirus Infection and Squamous Intraepithelial Lesions in HIV-Positive Patients Enrolled in AIDS Cancer Clinical Trials (NCT00695422) | AIDS Malignancy Consortium | 2008-05-14 |
| Three Different Therapy Regimens in Treating Patients With Previously Untreated Hodgkin Lymphoma (NCT00920153) | French Innovative Leukemia Organisation | 2008-05-01 |
| Clofarabine and Rituximab in Treating Patients With Relapsed Non-Hodgkin Lymphoma (NCT00691652) | OHSU Knight Cancer Institute | 2008-05-01 |
| Educational and Skills Training Program for Parents of Childhood Cancer Survivors Who Have Neurobehavioral Dysfunction (NCT00713505) | City of Hope Medical Center | 2008-05-01 |
| Open-label Leucovorin Pharmacokinetic Study in Patients Receiving High Dose Methotrexate With or Without Voraxaze (NCT00634504) | BTG International Inc. | 2008-05-01 |
| Everolimus in Treating Older Patients With Mantle Cell Lymphoma Previously Treated With First-Line or Second-Line Chemotherapy (NCT00727207) | Technical University of Munich | 2008-05-01 |
| Perceptions of Burden in Patients With Late-Stage Cancer and Their Caregivers (NCT00770419) | Rutgers, The State University of New Jersey | 2008-05-01 |
| PET Study in Patients With Non-Hodgkin Lymphoma (NCT00712556) | Vanderbilt-Ingram Cancer Center | 2008-05-01 |
| A Study of Bone Marrow Transplantation Using Fully-Matched Relatives as Donors for Patients With Hematological Malignancies (NCT01315132) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2008-04-10 |
| Trial of Vorinostat in Combination With Cyclophosphamide, Etoposide, Prednisone and Rituximab for Elderly Patients With Relapsed Diffuse Large B-Cell Lymphoma (DLBCL) (NCT00667615) | Memorial Sloan Kettering Cancer Center | 2008-04-01 |
| Personalized Information or Basic Information in Helping Patients Make Decisions About Participating in a Clinical Trial (NCT00750009) | Case Comprehensive Cancer Center | 2008-04-01 |
| Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed Follicular Non-Hodgkin Lymphoma (NCT00637832) | University of Southampton | 2008-04-01 |
| Prevention of Left Ventricular Dysfunction During Chemotherapy (NCT01110824) | Hospital Clinic of Barcelona | 2008-04-01 |
| Rituximab and Denileukin Diftitox in Treating Patients With Previously Untreated Stage III or Stage IV Follicular B-Cell Non-Hodgkin's Lymphoma (NCT00460109) | Alliance for Clinical Trials in Oncology | 2008-04-01 |
| Yttrium-90 Ibritumomab Tiuxetan Plus High-Dose BEAM Followed By ASCT For Relapsed B-Cell Non-Hodgkin Lymphoma (NCT00695409) | City of Hope Medical Center | 2008-03-18 |
| SNX-5422 to Treat Solid Tumor Cancers and Lymphomas (NCT00644072) | National Cancer Institute (NCI) | 2008-03-07 |
| Gemcitabine and Bexarotene in Treating Patients With Progressive or Refractory Stage IB, Stage II, Stage III, or Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma (NCT00660231) | University College, London | 2008-03-01 |
| Metformin and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumor or Lymphoma (NCT00659568) | London Health Sciences Centre | 2008-03-01 |
| Safety Study Of SNX-5422 To Treat Solid Tumor Cancers And Lymphomas (NCT00647764) | Esanex Inc. | 2008-03-01 |
| Vandetanib and Bevacizumab in Treating Patients With Advanced Solid Tumors or Lymphoma (NCT00734890) | National Institutes of Health Clinical Center (CC) | 2008-03-01 |
| NPI-0052 and Vorinostat in Patients With Non-small Cell Lung Cancer, Pancreatic Cancer, Melanoma or Lymphoma (NCT00667082) | Celgene | 2008-03-01 |
| Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma Patients (NCT00651755) | M.D. Anderson Cancer Center | 2008-03-01 |
| Early Detection of Graft-Versus-Host Disease in Patients Undergoing a Donor Bone Marrow Transplant (NCT00898612) | Mayo Clinic | 2008-03-01 |
| Epratuzumab and Rituximab in Treating Patients With Previously Untreated Follicular Non-Hodgkin Lymphoma (NCT00553501) | Alliance for Clinical Trials in Oncology | 2008-03-01 |
| Combination Chemotherapy in Treating Younger Patients With Hodgkin Lymphoma (NCT00666484) | University College, London | 2008-03-01 |
| High-Dose Chemotherapy Given Together With Peripheral Blood Stem Cell Transplant in Treating Patients With Intestinal T-Cell Lymphoma (NCT00669812) | Cancer Research UK | 2008-02-01 |
| Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer (NCT00516503) | Alliance for Clinical Trials in Oncology | 2008-02-01 |
| Phase 1b Lymphoma Study of AMG 655 in Combination With Bortezomib or Vorinostat (NCT00791011) | Amgen | 2008-02-01 |